Rabbit liver tissue pieces and blocks are extensively used research biospecimens in hepatology, toxicology, pharmacology, metabolism, pathology, and translational biomedical research. The rabbit (Oryctolagus cuniculus) liver provides a valuable experimental model for investigating hepatic physiology, xenobiotic metabolism, fibrosis, regenerative responses, and liver injury. Compared with mice and other small laboratory rodents, rabbit liver provides larger tissue specimens that facilitate histopathological evaluation, molecular analyses, imaging studies, and ex vivo experimental approaches. Rabbit liver tissues are widely used to investigate drug-induced liver injury (DILI), hepatic lipid metabolism, oxidative stress, inflammation, hepatic fibrosis, liver regeneration, and ischemia–reperfusion injury, as well as for validating preclinical biomarkers of liver injury and evaluating emerging therapeutic strategies.

Key Features

• Preserved Hepatic Architecture : Maintains native hepatic architecture, including hepatocytes, hepatic lobules, portal triads, hepatic sinusoids, Kupffer cells, and central veins.

• Broad Analytical Compatibility : Suitable for histology, immunohistochemistry (IHC), immunofluorescence (IF), RNA, DNA, protein, transcriptomic, proteomic, metabolomic, and multi-omics analyses.

• Supports Hepatic Metabolism Studies : Compatible with studies of hepatic metabolism, xenobiotic biotransformation, cytochrome P450 enzyme expression and activity, pharmacokinetics, and toxicological mechanisms.

• Ideal for Liver Disease Research : Valuable for research on hepatic fibrosis, steatosis, oxidative stress, inflammation, ischemia–reperfusion injury, liver regeneration, and experimental liver diseases.

• Large Tissue Specimens : Support serial sectioning, quantitative histopathology, spatial molecular profiling, imaging-based analyses, and reproducible experimental workflows.

Typical Research Applications

• Drug-induced liver injury (DILI) and hepatotoxicity studies.

• Hepatic fibrosis, extracellular matrix remodeling, and chronic liver disease research.

• Diet-induced steatosis, lipid metabolism, and metabolic dysfunction-associated steatotic liver disease (MASLD)/non-alcoholic fatty liver disease (NAFLD) investigations.

• Xenobiotic metabolism, cytochrome P450 enzyme characterization, pharmacokinetic, and pharmacodynamic studies.

• Liver regeneration, ischemia–reperfusion injury, oxidative stress, inflammatory signaling, biomarker discovery, and preclinical therapeutic evaluation.